Products
Platform
Research
Market
Learn
Compare LIC MF Healthcare Fund vs UTI Healthcare Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹200 | ₹500 |
Expense Ratio | 2.45 | 2.26 |
NAV | ₹29.23 | ₹286.23 |
Fund Started | 08 Feb 2019 | 01 Aug 2005 |
Fund Size | ₹86.00 Cr | ₹1126.13 Cr |
Exit Load | Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹200
₹500
Expense Ratio
2.45
2.26
NAV
₹29.23
₹286.23
Fund Started
08 Feb 2019
01 Aug 2005
Fund Size
₹86.00 Cr
₹1126.13 Cr
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Exit load of 1% if redeemed within 30 days.
Returns
1 Year | -4.44% | -1.56% |
3 Year | 19.43% | 23.63% |
5 Year | 12.15% | 15.57% |
1 Year
-4.44%
-1.56%
3 Year
19.43%
23.63%
5 Year
12.15%
15.57%
Holding Analysis
Equity | 98.46% | 98.75% |
Cash | 1.54% | 1.24% |
Equity
98.46%
98.75%
Cash
1.54%
1.24%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.47% |
Apollo Hospitals Enterprise Ltd. | 5.73% |
Torrent Pharmaceuticals Ltd. | 5.68% |
Cipla Ltd. | 5.56% |
Neuland Laboratories Ltd. | 4.85% |
Divi's Laboratories Ltd. | 4.64% |
Fortis Healthcare Ltd. | 4.50% |
Aurobindo Pharma Ltd. | 4.46% |
Piramal Pharma Ltd. | 4.32% |
Alkem Laboratories Ltd. | 3.41% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.76% |
Ajanta Pharma Ltd. | 6.48% |
Lupin Ltd. | 5.91% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Dr. Reddy's Laboratories Ltd. | 3.74% |
Gland Pharma Ltd. | 3.46% |
Apollo Hospitals Enterprise Ltd. | 3.45% |
Alkem Laboratories Ltd. | 3.43% |
Procter & Gamble Health Ltd. | 3.41% |
Cipla Ltd. | 3.40% |
Fund Manager
Name | Karan Doshi | Kamal Gada |
Start Date | 31 Oct 2025 | 02 May 2022 |
Name
Karan Doshi
Kamal Gada
Start Date
31 Oct 2025
02 May 2022
About Fund
Description | The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 08 Feb 2019 | 01 Aug 2005 |
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
08 Feb 2019
01 Aug 2005